DAWN BEST: Open Payments
NPI 1003049925 · MOUNTAIN HOME, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 21 payments from 8 companies in 2025. Trend: 2023 $218 · 2024 $248 · 2025 $493
Food & beverage: $448Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $218 |
| Lilly USA, LLC | 3 | $91 |
| PFIZER INC. | 3 | $51 |
| Exact Sciences Corporation | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: UBRELVY, NURTEC ODT, Cologuard Collection Kit, MOUNJARO, QULIPTA, FARXIGA, FANAPT, Wegovy.
Industry payments across ID — which companies pay providers there.
